Moderna, Inc. (MRNA)
42.18
+0.35
(+0.84%)
USD |
NASDAQ |
Jan 20, 11:06
Moderna EPS Diluted (Quarterly): -0.5128 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Merck & Co., Inc. | 2.316 |
| Pfizer Inc. | 0.6197 |
| Novavax, Inc. | -1.246 |
| Johnson & Johnson | 2.121 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -200.00M |
| Revenue (Quarterly) | 1.016B |
| Total Expenses (Quarterly) | 1.216B |
| Enterprise Value | 12.57B |
| Gross Profit Margin (Quarterly) | 74.51% |
| Profit Margin (Quarterly) | -19.68% |
| Earnings Yield | -19.12% |
| Normalized Earnings Yield | -19.12 |